United States · Lifestyle programme · No medication — programme only
Virta Health review
The only service here that does not prescribe GLP-1s at all — and positions itself explicitly as the offramp from them.
Overview
Virta belongs in this research precisely because it is not selling a GLP-1. It describes a “nutrition-first approach” aimed at weight loss and diabetes reversal, and positions itself as “a powerful complement, offramp, and alternative to weight loss medications.” That word offramp is doing real work: it names the problem every subscription on this site quietly creates.
The claimed one-year results are specific: 31 lbs average weight loss, 63% of members eliminating diabetes medications, and an average A1c reduction of 1.3. Those are the company’s own figures, published without a trial citation, and should be read as marketing claims rather than as the trial endpoints quoted elsewhere on this site.
Support is a health coach and a care team through an app. Virta does not specify clinician credentials or the nature of medical oversight on the page we checked, and publishes no pricing at all. Access runs through individuals, employers and health plans.
Medications and supply
No medication. Virta describes itself as a complement, offramp and alternative to weight-loss medications rather than a prescriber of them.
- None — Virta does not prescribe GLP-1s
How the service works
- Consultation
- Enrolment into a coached nutrition programme rather than a prescribing consultation.
- Eligibility
- Not stated in detail. Access runs through individuals, employers and health plans.
- Provider involvement
- A health coach and a care team via the app. Clinician credentials and the nature of medical oversight are not specified on the page.
- Lab requirements
- Not stated in the sources we checked.
- Pharmacy fulfilment
- Not stated in the sources we checked.
- Shipping
- Not stated in the sources we checked.
- Support services
- Health coach and care team through the app, with personalised nutrition plans.
What it costs
| Item | Published price | Notes |
|---|---|---|
| Programme cost | not published | available via individuals, employers and health plans |
- Membership fee
- Not stated in the sources we checked.
- Medication fee
- Not applicable — no medication is prescribed.
- Insurance
- Distributed through employers and health plans as well as direct enrolment. Coverage terms are not published.
- HSA / FSA
- Not stated in the sources we checked.
- Cancellation
- Not stated in the sources we checked.
- Refunds
- Not stated in the sources we checked.
Pros
- The only service here that treats coming off medication as the goal rather than a problem
- Nutrition-first, with a named coach rather than a prescription funnel
- Publishes specific one-year outcome claims
- No medication risk, because there is no medication
Cons
- No pricing published anywhere
- Outcome figures are company claims without a trial citation
- Clinician credentials and medical oversight are not specified
- Nothing published on cancellation, refunds or eligibility
Who it may suit
Someone who wants a structured alternative to medication, or a plan for what happens after stopping one.
Limitations
- Not a route to a GLP-1 prescription — that is the entire point
- Its published results are not comparable to the trial endpoints quoted elsewhere on this site
Questions
Does Virta prescribe GLP-1s?
No. It describes itself as a complement, offramp and alternative to weight-loss medications, which makes it the odd one out in this research and the reason it is included.
Are the 31 lbs and 63% figures trial results?
No. They are Virta’s own published one-year member figures, without a trial citation. Treat them differently from the SURMOUNT-1 or STEP 1 endpoints quoted elsewhere on this site.
Sources
Everything on this page traces to one of the links below, retrieved on the date shown. Prices and programme terms in this market change without notice — confirm against the provider before you buy.
- 01Virta Health — programme model, positioning, published one-year resultsretrieved 2026-08-15